(VIANEWS) – The Market ended the session with NYXOAH (NYXH.BR) jumping 29.37% to €11.10 on Wednesday while BEL 20 jumped 1.52% to €4,029.25.
NYXOAH’s last close was €8.58, 51.25% below its 52-week high of €17.60.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.55.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.58%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 8.7% and a drop 2.2% for the next.
Volatility
NYXOAH’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.60%, a negative 0.05%, and a positive 5.33%.
NYXOAH’s highest amplitude of average volatility was 5.39% (last week), 4.49% (last month), and 5.33% (last quarter).
More news about NYXOAH (NYXH.BR).
